CG
Carter Gould Cantor Fitzgerald Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
26
Skillsoft
SKIL
$114M
| $13.30 | $20 |
50%
upside
| Overweight |
16 Apr ‘24
1 year ago |
|
27
Arcellx
ACLX
$4.31B
| $77.68 | $73 |
6%
downside
| Overweight |
29 Feb ‘24
1 year ago |
|
28
Alector
ALEC
$290M
| $2.87 | $12 |
318%
upside
| Overweight |
5 May ‘23
2 years ago |
|
29
Gossamer Bio
GOSS
$787M
| $3.46 | $1.50 |
57%
downside
| Equal-Weight |
21 Mar ‘23
2 years ago |
|
30
Applied Therapeutics
APLT
$63.6M
| $0.4414 | $2.25 |
410%
upside
| Equal-Weight |
16 Aug ‘22
3 years ago |
|
31
Paycom
PAYC
$12.7B
| $226.37 | $380 |
68%
upside
| Equal-Weight |
20 Jan ‘22
3 years ago |
|
32
Regeneron Pharmaceuticals
REGN
$60.2B
| $568.20 | $440 |
23%
downside
| Buy |
8 May ‘19
6 years ago |
|
33
Gilead Sciences
GILD
$146B
| $117.86 | $77 |
35%
downside
| Buy |
10 Apr ‘19
6 years ago |
|
34
Incyte
INCY
$16.8B
| $86.17 | $82 |
5%
downside
| Neutral |
16 Jan ‘19
6 years ago |
|
35
Vertex Pharmaceuticals
VRTX
$102B
| $397.37 | $188 |
53%
downside
| Neutral |
26 Jul ‘18
7 years ago |
|